These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 33109306)

  • 1. Chronic rhinosinusitis with nasal polyps management in the age of biologics.
    Blaiss MS
    Allergy Asthma Proc; 2020 Nov; 41(6):413-419. PubMed ID: 33109306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics].
    Hoffmann AS; Betz CS; Böscke R; Weber RK
    HNO; 2024 Apr; 72(4):225-230. PubMed ID: 38376799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
    Favier V; Daveau C; Carsuzaa F; Fieux M; Vandersteen C; Castillo L; Papon JF; de Gabory L; Saroul N; Verillaud B; Rumeau C; Jankowski R; Michel J; de Bonnecaze G; Lecanu JB; Coste A; Béquignon E; Malard O; Mortuaire G
    BMJ Open; 2024 May; 14(5):e083112. PubMed ID: 38749694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for chronic rhinosinusitis with nasal polyps.
    Wallace DV
    Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152
    [No Abstract]   [Full Text] [Related]  

  • 6. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of biologics in chronic sinusitis with nasal polyps.
    Wang C; Zhang L
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
    Brown WC; Senior B
    Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
    Bachert C; Desrosiers MY; Hellings PW; Laidlaw TM
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1099-1106. PubMed ID: 33227522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts.
    Carsuzaa F; Fath L; Fieux M; Bartier S; de Bonnecaze G; Rumeau C; Michel J; Papon JF; Alexandru M; Favier V
    Expert Rev Clin Immunol; 2023; 19(8):1005-1011. PubMed ID: 37327360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unified Airway Disease: Medical Management.
    Shamil E; Hopkins C
    Otolaryngol Clin North Am; 2023 Feb; 56(1):157-168. PubMed ID: 36266108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
    Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biologics: A New Option in Treatment of Severe Chronic Rhinosinusits with Nasal Polyps].
    Cuevas M; Zahnert T
    Laryngorhinootologie; 2021 Feb; 100(2):134-145. PubMed ID: 33525013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective.
    van der Lans RJL; Hopkins C; Senior BA; Lund VJ; Reitsma S
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1454-1461. PubMed ID: 35231626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP.
    Guo CL; Liu FF; Wang DY; Liu Z
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):703-713. PubMed ID: 37987873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.